(Q51375119)
Statements
1 reference
Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes. (English)
1 reference
1 reference
Giovanni Annuzzi
1 reference
Giuseppina Della Corte
1 reference
Paola Cipriano
1 reference
Anna Mangione
1 reference
Gabriele Riccardi
1 reference
Angela A Rivellese
1 reference
15 March 2011
1 reference
1 reference
217
1 reference
1
1 reference
142-148
1 reference
Identifiers
1 reference